Semaglutide Use Increases Risk of Optic Neuropathy
Drug Topics
JULY 8, 2024
Researchers addressed the association between semaglutide use and the risk of nonarteritic anterior ischemic optic neuropathy.
Drug Topics
JULY 8, 2024
Researchers addressed the association between semaglutide use and the risk of nonarteritic anterior ischemic optic neuropathy.
STAT
JULY 8, 2024
Come quickly, the Columbus Police sergeant urged, patients are in danger. The psychiatric hospital on the city’s east side may need to be shut down, he warned Ohio regulators. The officer, a 27-year veteran of the department, knew that sending the February letter was an unusual thing to do, but meetings with hospital leaders had gone nowhere, and he was at his wit’s end.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
JULY 8, 2024
When used together, sodium glucose co-transporter 2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) were able to lower the risk of major adverse cardiovascular events and kidney disease by 11% and 33%, respectively.
STAT
JULY 8, 2024
Imagine this post-9/11 scenario: A New York City fire company is forced to shut down and lay off its firefighters because some Americans believe a bizarre conspiracy theory that this fire company brought down the World Trade Center towers. A Covid-19 version of this freakish tale is happening today. Instead of a fire company, the conspiracy gang is targeting an important, successful, decades-old nonprofit organization that researches viral epidemics and tries to predict and forestall future
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Fierce Healthcare
JULY 8, 2024
U.S. digital health startups pulled in $5.7 billion across 266 deals in the first six months of 2024, marking continued momentum in the sector after a rocky few quarters last year. | U.S. digital health startups pulled in $5.7 billion across 266 deals in the first six months of 2024, marking continued momentum in the sector after a rocky few quarters last year.
STAT
JULY 8, 2024
In a long-awaited study, patients in Australia will soon receive an IV infusion designed to transform their own immune cells into swarms of cancer-fighting drones. The trial, announced on Tuesday by Interius Biotherapeutics, will be the first to test what’s known technically as in vivo CAR-T therapy. Researchers have long hoped the approach could provide a potentially cheaper, safer, and more scalable version of the cell therapies that are curative for some blood cancer patients but remai
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
JULY 8, 2024
A study published Monday provides new evidence that the H5N1 virus currently causing an outbreak of bird flu in U.S. dairy cattle may be adapted to better infecting humans than other circulating strains of the virus, a result that is already courting controversy among the world’s leading flu researchers. Across the globe, different influenza viruses are constantly circulating in many different kinds of animals.
Fierce Healthcare
JULY 8, 2024
The portion of physicians surveyed by the American Medical Association (AMA) who report at least one symptom of burnout has dropped below 50%, a first since the onset of the COVID-19 pandemic. | The American Medical Association, which often cites burnout as a key threat to the well-being of the profession and the long-term supply of medical professionals, celebrated the results but said there’s still work to be done.
STAT
JULY 8, 2024
Medical milestones broadcast via tweet. Scientific progress revealed via live YouTube demo. Teasers for updates followed by a livestream from a patient’s home. These aren’t the latest social media influencer tactics, but the way Neuralink, Elon Musk’s neurotechnology company, has disseminated information about its medical research.
Fierce Healthcare
JULY 8, 2024
In a study published in JAMA Network Open on Tuesday, Included Health and Harvard Medical School found that patients in high deductible health plans are less likely to seek virtual behavioral healt | A study by Included Health and Harvard Medical School found that when cost-sharing is reintroduced for telehealth visits for patients in high-deductible health plans, patients will use fewer services.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT
JULY 8, 2024
The Biden administration has appealed a decision in which a federal court jury last year sided with Gilead Sciences over the rights to a pair of groundbreaking HIV pills — and at least $1 billion in royalties may be at stake. At issue is a battle over patents for Truvada and a newer, upgraded version version called Descovy — two highly effective and lucrative medications — as well as the role played by the federal government in making it possible to prevent transmission of a
Drug Topics
JULY 8, 2024
Current recommendations suggest women receive the RSV vaccine between 32 and 36 weeks' gestational age.
STAT
JULY 8, 2024
Bird flu snapshot: This is the latest installment in a series of regular updates on H5N1 avian flu that STAT is publishing on Monday mornings. To read future updates, you can also subscribe to STAT’s Morning Rounds newsletter. Last week, following an unusually udder pun-laden discussion , lawmakers in Delaware voted to become the latest state to legalize the sale of raw milk.
Fierce Healthcare
JULY 8, 2024
A variety of government and healthcare organizations are now eligible to tap into newly announced funding by the Department of Health and Human Services. | The funding will support community-based maternal behavioral health services and a women’s behavioral health technical assistance center.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
JULY 8, 2024
South African antitrust authorities ended an investigation into Johnson & Johnson and its Janssen subsidiary over “excessive pricing” of a lifesaving tuberculosis drug after the companies took steps to lower the cost and widen access to the medicine. In a brief statement , the Competition Commission explained that J&J and Janssen agreed not to enforce a so-called secondary patent on bedaquiline, which is also sold under the brand name Sirturo, a step that makes it possible
Fierce Healthcare
JULY 8, 2024
Two high-ranking government officials have abdicated their roles on the board of the Coalition for Health AI, the organization and HHS confirmed. The breakup is a strong departure from th | Micky Tripathi and Troy Tazbaz have officially stepped down from their Board-level federal liaison roles at the Coalition for Health AI, one of the nation's largest healthcare AI standards organizations.
Fierce Pharma
JULY 8, 2024
Is Eli Lilly’s Mounjaro or Novo Nordisk’s Ozempic more effective in helping patients lose weight? | Is Eli Lilly’s Mounjaro or Novo Nordisk’s Ozempic more effective in helping patients lose weight? While a head-to-head trial pitting the two treatments remains ongoing, new evidence shows that Lilly’s tirzepatide may be the superior weight loss product.
Fierce Healthcare
JULY 8, 2024
Nearly 5 million fewer people delayed care from 2019 to 2022, a study from the Urban Institute with funding from the Robert Wood Johnson Foundation revealed. | Pandemic-era policies appear to have helped almost 5 million people access necessary medical care that they otherwise may not have been able to, a recent report shows.
Drug Topics
JULY 8, 2024
Results of a new survey show that individuals with dry eye believe the condition is something “people must learn to live with.
STAT
JULY 8, 2024
Funding for health tech startups in the first half of 2024 remained far below the high levels seen immediately after the Covid-19 pandemic, but several indicators suggest stability — and maybe even a brewing comeback for the sector. Health tech startups raised $5.7 billion in the first half of the year, putting them on pace to just exceed the $10.7 billion total raised in 2023, according to a report from Rock Health , which invests in companies and provides advisory services.
Fierce Pharma
JULY 8, 2024
After a drawn-out litigation process, Merck & Co. seems to have finally washed its hands of more than a thousand lawsuits tied to its shingles vaccine Zostavax. | A U.S. appeals court has tossed a request to resurrect certain lawsuits claiming Merck’s popular shot Zostavax caused patients to develop shingles. The court made its decision after the plaintiffs filed a voluntary dismissal some two years after logging a loss in Pennsylvania.
STAT
JULY 8, 2024
You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow of money in medicine. Sign up to get it in your inbox every Monday. Lifting the veil on psychiatric hospital joint ventures Nonprofit hospital systems are opening psychiatric hospitals to help the growing number of people suffering from mental health problems.
Pharmacy Times
JULY 8, 2024
By developing the Shizuoka score, which features a new predictive model using machine learning, patients with Kawasaki disease who are non-responders to intravenous immunoglobulin were able to be accurately identified.
STAT
JULY 8, 2024
Eli Lilly said Monday it will acquire Morphic Holding, a biotech developing a treatment for inflammatory bowel disease. Lilly will pay about $3.2 billion to buy the Waltham, Mass.-based company. That translates to $57 per share, a premium of roughly 79% from Morphic’s Friday closing price. Morphic’s lead candidate, MORF-057, is an oral small molecule that blocks α4β7 integrin.
Fierce Pharma
JULY 8, 2024
After announcing plans last year to expand manufacturing in its home country, Korean CDMO newcomer Lotte Biologics has kicked off work on a sprawling facility along Incheon’s waterfront near Seoul. | Late last week, Lotte Biologics broke ground on its flagship facility at the Songdo Bio Campus in Incheon International City, South Korea. The company is pitching the production effort as a key part of its quest to become one of the top 10 CDMOs in the world.
The Checkup by Singlecare
JULY 8, 2024
The Centers for Disease Control and Prevention (CDC) estimates that 1 million Americans get shingles every year , and the National Institute on Aging says about half of those cases are in adults ages 60 or older. Shingles (herpes zoster) are caused by the varicella-zoster virus, which also causes chickenpox. Shingles can cause a painful rash, blisters, and post-herpetic neuralgia (PHN).
Fierce Pharma
JULY 8, 2024
Novo Nordisk’s massively successful GLP-1 analog semaglutide, the active ingredient in the popular diabetes and obesity meds Ozempic and Wegovy, may be linked to a vision loss disorder, a new | Novo Nordisk’s popular GLP-1 analog semaglutide may be linked to a vision loss disorder, a study suggests. But one team of analysts cautioned against reading too much into the analysis.
The Checkup by Singlecare
JULY 8, 2024
Adderall, sold under the generic version of amphetamine/dextroamphetamine) is a stimulant medication approved by the U.S. Food and Drug Administration to treat the symptoms of attention deficit hyperactivity disorder ( ADHD ). Adderall is also used to help people with narcolepsy stay awake during the day. There are two types of Adderall: Adderall IR and Adderall XR.
pharmaphorum
JULY 8, 2024
A recent healthcare report conducted by Edelman reveals a concerning trend of declining public trust in healthcare institutions. Explore the key findings and implications in this comprehensive analysis.
The Checkup by Singlecare
JULY 8, 2024
Atopic dermatitis, also known as eczema , is a skin condition that causes dry, itchy, irritated skin. According to the National Institutes of Health , eczema affects 15%–30% of children and 2%–10% of adults at some point in their life. There is no cure for eczema , but symptoms can be managed with moisturizers, topical corticosteroids , systemic treatments, or a combination of them all.
STAT
JULY 8, 2024
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hello! Hope your weekend was a blissful one. Today, we talk about AbbVie’s outsize marketing spend, see how GLP-1s are impacting cancer rates, and more.
The Checkup by Singlecare
JULY 8, 2024
Dupixent (dupilumab) is a brand-name medication that has been approved by the Food and Drug Administration (FDA) to treat the following conditions: Moderate-to-severe atopic dermatitis (the most common type of eczema) in adults and children 6 months and older Moderate to severe eosinophilic asthma or asthma that is dependent on oral steroid medications in adults and children 6 years and older Chronic rhinosinusitis with nasal polyps in adults 18 years and older Prurigo nodularis in adults 18 ye
Pharmacy Times
JULY 8, 2024
When used correctly, weight-loss medications, such as glucagon-like peptide-1 (GLP-1) medications, can be a tool to help reduce costs and provide clinical results.
The Checkup by Singlecare
JULY 8, 2024
People with certain mood disorders, such as schizophrenia and bipolar disorder , may be prescribed a drug called Vraylar (cariprazine) to help manage their symptoms. It’s an atypical antipsychotic medication that affects both dopamine and serotonin receptors, says Alyssa Dweck, MD , OB-GYN and women’s health expert for INTIMINA. It’s also relatively new: Vraylar came on the market in 2015, and the Food and Drug Administration (FDA) has been slowly approving it for different uses since the
Let's personalize your content